Xing Qi Eye Medicine (300573.SZ) released its half-year performance, with a net profit attributable to the mother of 335 million yuan, an increase of 97.75%

The Zhitong Finance APP reported that Xingqi Eye Medicine (300573.SZ) released its 2025 interim report, with the company's operating income amounting to 1.163 billion yuan, a year-on-year increase of 30.38%. The net profit attributable to shareholders of the listed company was 335 million yuan, an increase of 97.75% year-on-year. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 331 million yuan, an increase of 96.30% year-on-year. The basic earnings per share were 1.36 yuan.